What You Need to Know About IVIG Therapy for Kawasaki Disease 2025
Dr. Alex Villa-Forte, Staff Physician at the Center for Vasculitis Care and Research at the Cleveland Clinic, reviews the treatment, IVIG. The treatment has been approved for us for Kawasaki disease. She discusses how IVIG works, possible side effects/risks, and what we have learned about this drug over the last few years. 0:00 2:05 What is IVIG? 4:34 What does IVIG do? 6:20 Possible side effects and risks. 7:26 Who can be treated with IVIG? 8:47 What have we learned about IVIG since we started using it for Kawasaki disease? 11:10 What is the dosing frequency for IVIG? 13:19 Why hasn’t the FDA approved IVIG for other forms of vasculitis? 16:05 Was IVIG used during COVID? What you need to know about IVIG Therapy July 2025 Visit the Vasculitis Foundation (www.vasculitisfoundation.org).
Evolution of Vasculitis Timeline: Past Lessons, Present Advances, Future Hope 2026
What You Need to Know About UPLIZNA® Part 2: Q&A
IVIG Side Effects: What You Should Know
Avacopan (Tavneos®) in GPA and MPA 2026
Something is jamming GPS over Europe. Here's what we found
IVIG Therapy in 2025: Side Effects, Cost, and What’s Changed
Hydroxychloroquine - everything you need to know about this common rheumatology medication
IVIG: What Families Need To Know
Doctor reveals undisclosed risks of COVID-19 vaccine
Kawasaki Disease Explained (Includes Criteria & Mnemonic)
Think You Know IVIG? This Might Change Your Mind!
IVIG for Small Fiber Neuropathy: 6 Key Steps To Insurance Approval
IVIG (Intravenous Immunoglobulin) for Multiple Myeloma
What You Need to Know About Avacopan (Tavneos®) for GPA/MPA -Part One 2025
Vasculitis Journeys Revisited: Featuring Brook Raphael
IVIG Therapy - A Beginner’s Guide
Kawasaki Disease vasculitis - symptoms, pathophysiology, treatment
MTHFR: The Root Cause of Fatigue That Doctors Call ‘Normal‘
What You Need to Know About Apremilast (Otezla®) for Behcet's Syndrome 2025
